ALS Patients Show Gains in Ongoing Study of MediciNova’s Ibudilast Therapy
MediciNova has presented positive interim data from an ongoing clinical trial to evaluate the efficacy and safety of MN-166 (ibudilast) in the treatment…
Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
MediciNova has presented positive interim data from an ongoing clinical trial to evaluate the efficacy and safety of MN-166 (ibudilast) in the treatment…
The Augmentative Communication Program (ACP) at Boston Children’s Hospital has received a $1.5 million donation to set up a program focused on…
Flex Pharma, Inc., a biotechnology company developing novel proprietary treatments for spasms and nocturnal and exercise muscle cramps associated with…
MediciNova, Inc., a biopharmaceutical company that acquires and develops novel, small-molecule therapeutics for diseases with unmet medical needs, recently…
A new multidisciplinary clinic, the Jefferson Weinberg ALS Center, has announced it will open its doors on January 8th 2016. The new clinic…
The first transgenic mouse model for the most common type of the familial form of amyotrophic lateral sclerosis (ALS, or Lou…
In a recent study published in the Journal of Comparative Neurology, researchers found that the same sensory neurons that…
MediciNova, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has approved the protocol of a novel…
The winners of the DREAM ALS Stratification Prize4Life Challenge were recently announced by Prize4Life, Sage Bionetworks and the DREAM…
Researchers at the University of Edinburgh studied the effect of the hormone serotonin in the regeneration of motor neurons after…